Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
University Hospitals Coventry and Warwickshire NHS Trust
UMC Utrecht
University Health Network, Toronto
University of Aarhus
Mayo Clinic
M.D. Anderson Cancer Center
University of Washington
Sun Yat-sen University
M.D. Anderson Cancer Center